RMgmDB - Rodent Malaria genetically modified Parasites

Back to search results

Summary

RMgm-1157
Malaria parasiteP. berghei
Genotype
MutatedGene model (rodent): PBANKA_1243100; Gene model (P.falciparum): PF3D7_0528500; Gene product: F-actin-capping protein subunit alpha, putative (CPalpha, CPα)
Details mutation: P. berghei cpα replacement with the complete P. falciparum cpα gene
MutatedGene model (rodent): PBANKA_1232400; Gene model (P.falciparum): PF3D7_0517600; Gene product: F-actin-capping protein subunit beta, putative (CPbeta, CPβ, UIS17, upregulated in infectious sporozoites gene 17)
Details mutation: P. berghei cpα and cpβ gene replacement with the P. falciparum cpα and cpβ orthologs
Phenotype Oocyst; Sporozoite;
Last modified: 18 January 2015, 15:31
  *RMgm-1157
Successful modificationThe parasite was generated by the genetic modification
The mutant contains the following genetic modification(s) Gene mutation, Gene mutation
Reference (PubMed-PMID number) Reference 1 (PMID number) : 25565321
MR4 number
Parent parasite used to introduce the genetic modification
Rodent Malaria ParasiteP. berghei
Parent strain/lineP. berghei ANKA
Name parent line/clone Not applicable
Other information parent line
The mutant parasite was generated by
Name PI/ResearcherGanter M, Matuschewski K
Name Group/DepartmentParasitology Unit
Name InstituteF-actin-capping protein subunit alpha, putative
CityBerlin
CountryGermany
Name of the mutant parasite
RMgm numberRMgm-1157
Principal namecpα(-)::PfCPα X cpβ(-)::PfCPβ
Alternative name
Standardized name
Is the mutant parasite cloned after genetic modificationYes
Phenotype
Asexual blood stageNot different from wild type
Gametocyte/GameteNot different from wild type
Fertilization and ookineteNot different from wild type
OocystReduced numbers of oocysts. Oocysts produce midgut sporozoites.
SporozoiteReduced numbers of oocysts. Oocysts produce midgut sporozoites. Small numbers of sporozoites inside salivary glands that are infective to mice.
Liver stageNot tested
Additional remarks phenotype

Mutant/mutation
A double gene replacement mutant: In the mutant the P. berghei cpα and cpβ gene are replaced with the complete P. falciparum cpα and cpβ orthologs. The P. falciparum genes are under the control of the P. berghei cpα and cpβ promoter region, respectively. The mutant has been generated by crossing the single gene cpα replacement mutant RMgm-1154 with  the single gene cpβ replacement mutant RMgm-1156 in mosquitoes and selection of the double replacment mutant

Protein (function)
One of the few conserved actin-binding proteins of Plasmodium parasites is the F-actin capping protein (CP), which is found in all eukaryotic organisms and metazoan cell types

CP binds in a calcium-independent manner to the fast growing (barbed) ends of F-actin, thereby blocking subunit exchange. CP also belongs to the defined set of proteins that are needed to reconstitute actin-based motility in vitro.

Active CP is composed of two subunits, CPα and CPβ, and production of recombinant active CP in Escherichia coli (E. coli) is typically only achieved by co-expression of both subunits

Plasmodium CPβ is encoded by a single open reading frame, whereas CPα is composed of nine small exons. Overall, Plasmodium CPα-subunits share approximately 19% amino acid sequence identity with other eukaryotic CPα-subunits, and 50-90% identity across different Plasmodium species.

The residues that contribute to actin binding and heterodimer formation are conserved.

CPβ-subunit of rodent malaria parasite P. berghei (PbCPβ) as an essential regulator of sporozoite motility and malaria transmission. Deletion of PbCPβ did not influence asexual and sexual blood-stage development in the mammalian host. In the insect vector, Anopheles mosquitoes, mutant parasites displayed defective motility, which completely arrested life cycle progression at the sporozoite stage. It has been shown that recombinant P. berghei CPα/β heterodimers display capping activity on heterologous non-muscle actin. The stage-specific function of CPβ in sporozoites implies that CPα alone might be functional during blood infection of cpβ(-) parasites. Given that independent functions of CP subunits have not been described, this notion was unexpected and prompted to investigate the cellular role(s) of Plasmodium CPα for parasite life cycle progression.

In this study it is shown that the two CP subunits can be functionally separated. Unlike the beta subunit, the CPalpha subunit of the apicomplexan parasite Plasmodium is refractory to targeted gene deletion during blood infection in the mammalian host.

See the link F-actin-capping protein subunits for other mutants with mutated F-actin-capping protein subunits

Phenotype
Phenotype analyses of the single gene cpα replacement mutant RMgm-1154 indicate that P. falciparum CPα can fully complement P. berghei CPα during blood stage development. However, the mutant shows strongly reduced numbers of oocysts in A. stephensi mosquitoes and absence of salivary gland sporozites.

Phenotype analyses of with  the single gene cpβ replacement mutant RMgm-1156  show strongly reduced numbers of oocysts in A. stephensi mosquitoes and absence of salivary gland sporozites.

The double replacement P. berghei mutant in which both the cpα and cpβ genes are replaced with the complete P. falciparum cpα and cpβ genes (RMgm-1157) shows a partial rescue of the phenotype with low numbers of sporozoites present in salivary glands.

Combined these observations indicate that i) trans-species complementation of both subunits is needed to rescue the severe sporozoite defect as seen in both single replacement mutants and that ii) a functional CP heterodimer is necessary for normal oocyst and sporozoite development.

Additional information

Other mutants
See the link F-actin-capping protein subunits for other mutants with mutated F-actin-capping protein subunits


  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1243100
Gene Model P. falciparum ortholog PF3D7_0528500
Gene productF-actin-capping protein subunit alpha, putative
Gene product: Alternative nameCPalpha, CPα
Details of the genetic modification
Short description of the mutationP. berghei cpα replacement with the complete P. falciparum cpα gene
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationIn the mutant the P. berghei cpα and cpβ gene is replaced with the complete P. falciparum cpα and cpβ orthologs. The P. falciparum genes are under the control of the P. berghei cpα and cpβ promoter region, respectively. The mutant has been generated by crossing the single gene cpα replacement mutant RMgm-1154 with the single gene cpβ replacement mutant RMgm-1156.

For targeted disruption of PbCPα, two fragments were amplified from P. berghei genomic DNA as template using primers PbCPα_forI and PbCPα_revII to amplify the 5’ flanking region, and PbCPα_forIII and PbCPα_revIV for amplification of the 3’ flanking region. Cloning into the P. berghei transfection plasmid b3D.DT^H.^D resulted in the plasmid pPbCPαrep.

In order to complement cpα(-) parasites, we amplified the orthologous P. falciparum CPα gene using the primers PfCPα_compforV and PfCPα_comprevVI and P. falciparum cDNA as template. Cloning into the plasmid pPbCPαrep resulted in the complementation plasmid pPfCPα.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6

  Mutated: Mutant parasite with a mutated gene
Details of the target gene
Gene Model of Rodent Parasite PBANKA_1232400
Gene Model P. falciparum ortholog PF3D7_0517600
Gene productF-actin-capping protein subunit beta, putative
Gene product: Alternative nameCPbeta, CPβ, UIS17, upregulated in infectious sporozoites gene 17
Details of the genetic modification
Short description of the mutationP. berghei cpα and cpβ gene replacement with the P. falciparum cpα and cpβ orthologs
Inducable system usedNo
Short description of the conditional mutagenesisNot available
Additional remarks inducable system
Type of plasmid/construct(Linear) plasmid double cross-over
PlasmoGEM (Sanger) construct/vector usedNo
Modified PlasmoGEM construct/vector usedNo
Plasmid/construct map
Plasmid/construct sequence
Restriction sites to linearize plasmid
Selectable marker used to select the mutant parasitetgdhfr
Promoter of the selectable markerpbdhfr
Selection (positive) procedurepyrimethamine
Selection (negative) procedureNo
Additional remarks genetic modificationIn the mutant the P. berghei cpα and cpβ gene is replaced with the complete P. falciparum cpα and cpβ orthologs. The P. falciparum genes are under the control of the P. berghei cpα and cpβ promoter region, respectively. The mutant has been generated by crossing the single gene cpα replacement mutant RMgm-1154 with the single gene cpβ replacement mutant RMgm-1156.

To complement cpβ(-) parasites, we amplified the orthologous P. falciparum CPβ gene using the primers PfCPβ_compforV and PfCPβ_comprevVI and P. falciparum genomic DNA as template. Cloning into the plasmid pPbCPβREP (Ganter et al., 2009) resulted in the plasmid pPfCPβ with PfCPβ under the control of the endogenous PbCPβ promoter and the 3’ untranslated region of PbDHFR/TS.
Additional remarks selection procedure
Primer information: Primers used for amplification of the target sequences  Click to view information
Primer information: Primers used for amplification of the target sequences  Click to hide information
Sequence Primer 1
Additional information primer 1
Sequence Primer 2
Additional information primer 2
Sequence Primer 3
Additional information primer 3
Sequence Primer 4
Additional information primer 4
Sequence Primer 5
Additional information primer 5
Sequence Primer 6
Additional information primer 6